
Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
Here are three big reasons why, according to IP columnist Tom Kulik.
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
Please share your thoughts in this brief and anonymous survey.
A Kaiser Health News investigation shows that the system intended to help desperate patients is being manipulated by drugmakers to maximize profits,
Which Biglaw firm got blasted for ignoring its ethical obligations in a hostile takeover bid?
According to the Supreme Court, sometimes settling a lawsuit can create an antitrust problem. How?
Cops learn to hate people. Basically everyone they encounter is a criminal, so cops soon come to believe that everyone is a criminal. Litigators — or perhaps litigators who are repeat players in a particular field — learn to hate people. Personal injury insurance defense counsel come to believe that all plaintiffs are lying fakers. […]
A survey of professionals reveals the impact of legal work, clients, concerns, and future roles.
Columnist Mark Herrmann thinks that you should read the long piece in Fortune magazine about the rise and fall of Jeff Kindler as the CEO of Pfizer because it gives some insight on life as an in-house attorney....
This item, from yesterday’s WSJ Law Blog, caught our eye: As the 11th Vioxx trial got underway yesterday in federal court in New Orleans, Merck disclosed in an SEC filing that it’s giving its general counsel Kenneth Frazier a raise and a promotion, effective Nov. 1. The GC who will forever be associated with the […]